The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
FibroGen Inc’s recently made public that its Chief Medical Officer Adib Deyaa acquired Company’s shares for reported $25884.0 on Jun
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, FibroGen Inc revealed its Chief Medical Officer Adib Deyaa acquired Company’s shares for reported $25884.0 on Jun
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
FibroGen Inc’s filing revealed that its Chief Medical Officer Adib Deyaa acquired Company’s shares for reported $25884.0 on Jun 12
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
FibroGen Inc’s recent filing unveils that its CEO Wettig Thane acquired Company’s shares for reported $95470.0 on Mar 07 ’24.
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, FibroGen Inc revealed its CEO Wettig Thane acquired Company’s shares for reported $95470.0 on Mar 07 ’24.
